Arrowleaf

Arrowleaf, Legacy House

In the 2025 National Directory of Mental Health Treatment Facilities.

Type of Care

Substance use treatment (SA); Mental health treatment (MH)

Service Setting

Outpatient (OP); Residential/24-hour residential (RES)

Facility Type

Residential treatment center (RTC) for adults (RTCA)

Pharmacotherapies

Chlorpromazine (CHLOR); Fluphenazine (FLUPH); Haloperidol (HALOP); Perphenazine (PERPH); Aripiprazole (ARIPI); Asenapine (ASENA); Clozapine (CLOZA); Olanzapine (OLANZ); Olanzapine/Fluoxetine combination (OLANZ/FLUOX); Paliperidone (PALIP); Quetiapine (QUETI); Risperidone (RISPE); Ziprasidone (ZIPRA); Antipsychotics used in treatment of SMI (ANTPYCH)

Treatment Approaches

Activity therapy (AT); Cognitive behavioral therapy (CBT); Couples/family therapy (CFT); Group therapy (GT); Individual psychotherapy (IPT); Telemedicine/telehealth therapy (TELE); Abnormal involuntary movement scale (AIMS)

Emergency Mental Health Services

Crisis intervention team (CIT)

Facility Operation (e.g., Private, Public)

Private non-profit organization (PVTN)

Payment/Insurance/Funding Accepted

County or local government funds (CLF); Community Mental Health Block Grants (CMHG); Medicare (MC); Medicaid (MD); Other State funds (OSF); Private health insurance (PI); Cash or self-payment (CASH); State-financed health insurance plan other than Medicaid (SI); State welfare or child and family services funds (SWFS)

Assessment/Pre-treatment

Screening for tobacco use (STU)

Recovery Support Services

Mentoring/peer support (PEER)

Facility Smoking Policy

Smoking permitted in designated area (SMPD)

Age Groups Accepted

Young Adults (YAD); Seniors (SNR)

Facility Vaping Policy

Vaping permitted in designated area (VPPD)

Ancillary Services

Court-ordered outpatient treatment (COOT); Case management service (CM); Suicide prevention services (SPS)